Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1471-2407-12-134.

Title:
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers | BMC Cancer
Description:
Background Clinical relevance of tumor infiltrating lymphocytes (TILs) in breast cancer is controversial. Here, we used a tumor microarray including a large series of ductal and lobular breast cancers with long term follow up data, to analyze clinical impact of TIL expressing specific phenotypes and distribution of TILs within different tumor compartments and in different histological subtypes. Methods A tissue microarray (TMA) including 894 ductal and 164 lobular breast cancers was stained with antibodies recognizing CD4, FOXP3, and IL-17 by standard immunohistochemical techniques. Lymphocyte counts were correlated with clinico-pathological parameters and survival. Results CD4+ lymphocytes were more prevalent than FOXP3+ TILs whereas IL-17+ TILs were rare. Increased numbers of total CD4+ and FOXP3+ TIL were observed in ductal, as compared with lobular carcinomas. High grade (G3) and estrogen receptor (ER) negative ductal carcinomas displayed significantly (p < 0.001) higher CD4+ and FOXP3+ lymphocyte infiltration while her2/neu over-expression in ductal carcinomas was significantly (p < 0.001) associated with higher FOXP3+ TIL counts. In contrast, lymphocyte infiltration was not linked to any clinico-pathological parameters in lobular cancers. In univariate but not in multivariate analysis CD4+ infiltration was associated with significantly shorter survival in patients bearing ductal, but not lobular cancers. However, a FOXP3+/CD4+ ratio > 1 was associated with improved overall survival even in multivariate analysis (p = 0.033). Conclusions Ductal and lobular breast cancers appear to be infiltrated by different lymphocyte subpopulations. In ductal cancers increased CD4+ and FOXP3+ TIL numbers are associated with more aggressive tumor features. In survival analysis, absolute numbers of TILs do not represent major prognostic indicators in ductal and lobular breast cancer. Remarkably however, a ratio > 1 of total FOXP3+/CD4+ TILs in ductal carcinoma appears to represent an independent favorable prognostic factor.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

breast, cancer, foxp, cells, pubmed, ductal, google, scholar, article, infiltration, cancers, tumor, cas, lymphocytes, lobular, tils, prognostic, survival, lymphocyte, numbers, significantly, patients, total, carcinomas, analysis, data, herneu, tumors, expression, tissue, carcinoma, intratumoral, cell, high, infiltrating, basel, histological, grade, higher, regulatory, human, res, tumorinfiltrating, staining, increased, foxpcd, prognosis, figure, central, clinical,

Topics {✒️}

open access article pre-publication history t-cell-derived cytokine hypoxia-inducible factor-1alpha monoclonal anti-human cd163 paraffin-embedded tissue blocks 40x high-power-field early-onset breast carcinomas t-lymphocytes subsets endowed vitro-induced foxp3+cd8+ human tumor-specific cd8 inti zlobec tumor-infiltrating lymphocytes isolated unfavourable clinico-pathological features regulatory cd4+ t-cells author information authors article download pdf tumour-infiltrating lymphocytes cd4+ t-cells infiltration kaplan-meier survival curves b7-h1+/pd-1+ tumor-infiltrating lymphocyte subtype triple negative cancer il-17+tumor infiltrating lymphocytes tumor-infiltrating foxp3+ regulatory triple negative ductal t-cell subsets full access ductal carcinoma appears anti-cd4 antibody tumor suppressor gene t-cells expressing privacy choices/manage cookies anti-foxp3 antibody t-cell infiltration lymph node metastases human breast cancer adaptive immune system coya tapia pancreatic carcinoma cells breast cancer samples small breast cancers positive breast cancer early breast cancer lobular breast cancer expressing lobular carcinomas de andrade jm positive lymph nodes reliable treg markers human th17 cells

Questions {❓}

  • Roncarolo MG, Gregori S: Is FOXP3 a bona fide marker for human regulatory T cells?
  • Wilke CM, Kryczek I, Wei S, Zhao E, Wu K, Wang G, et al: Th17 cells in cancer: help or hindrance?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers
         description:Clinical relevance of tumor infiltrating lymphocytes (TILs) in breast cancer is controversial. Here, we used a tumor microarray including a large series of ductal and lobular breast cancers with long term follow up data, to analyze clinical impact of TIL expressing specific phenotypes and distribution of TILs within different tumor compartments and in different histological subtypes. A tissue microarray (TMA) including 894 ductal and 164 lobular breast cancers was stained with antibodies recognizing CD4, FOXP3, and IL-17 by standard immunohistochemical techniques. Lymphocyte counts were correlated with clinico-pathological parameters and survival. CD4+ lymphocytes were more prevalent than FOXP3+ TILs whereas IL-17+ TILs were rare. Increased numbers of total CD4+ and FOXP3+ TIL were observed in ductal, as compared with lobular carcinomas. High grade (G3) and estrogen receptor (ER) negative ductal carcinomas displayed significantly (p &lt; 0.001) higher CD4+ and FOXP3+ lymphocyte infiltration while her2/neu over-expression in ductal carcinomas was significantly (p &lt; 0.001) associated with higher FOXP3+ TIL counts. In contrast, lymphocyte infiltration was not linked to any clinico-pathological parameters in lobular cancers. In univariate but not in multivariate analysis CD4+ infiltration was associated with significantly shorter survival in patients bearing ductal, but not lobular cancers. However, a FOXP3+/CD4+ ratio &gt; 1 was associated with improved overall survival even in multivariate analysis (p = 0.033). Ductal and lobular breast cancers appear to be infiltrated by different lymphocyte subpopulations. In ductal cancers increased CD4+ and FOXP3+ TIL numbers are associated with more aggressive tumor features. In survival analysis, absolute numbers of TILs do not represent major prognostic indicators in ductal and lobular breast cancer. Remarkably however, a ratio &gt; 1 of total FOXP3+/CD4+ TILs in ductal carcinoma appears to represent an independent favorable prognostic factor.
         datePublished:2012-04-03T00:00:00Z
         dateModified:2012-04-03T00:00:00Z
         pageStart:1
         pageEnd:10
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2407-12-134
         keywords:
            Breast Cancer
            Ductal Carcinoma
            Lobular Carcinoma
            Tumor Infiltrate Lymphocyte
            Ductal Cancer
            Cancer Research
            Oncology
            Surgical Oncology
            Health Promotion and Disease Prevention
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig4_HTML.jpg
         isPartOf:
            name:BMC Cancer
            issn:
               1471-2407
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Raoul Droeser
               affiliation:
                     name:University Hospital Basel
                     address:
                        name:Department of Surgery, University Hospital Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
                     name:University of Basel
                     address:
                        name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Inti Zlobec
               affiliation:
                     name:University Hospital Bern
                     address:
                        name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
                        type:PostalAddress
                     type:Organization
                     name:University Hospital Basel
                     address:
                        name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ergin Kilic
               affiliation:
                     name:Charité University Hospital
                     address:
                        name:Institute for Pathology, Charité University Hospital, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Uwe Güth
               affiliation:
                     name:University Hospital Basel
                     address:
                        name:Department of Gynecology and Obstetrics, University Hospital Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael Heberer
               affiliation:
                     name:University of Basel
                     address:
                        name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giulio Spagnoli
               affiliation:
                     name:University of Basel
                     address:
                        name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daniel Oertli
               affiliation:
                     name:University Hospital Basel
                     address:
                        name:Department of Surgery, University Hospital Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Coya Tapia
               affiliation:
                     name:University Hospital Bern
                     address:
                        name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
                        type:PostalAddress
                     type:Organization
                     name:University Hospital Basel
                     address:
                        name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers
      description:Clinical relevance of tumor infiltrating lymphocytes (TILs) in breast cancer is controversial. Here, we used a tumor microarray including a large series of ductal and lobular breast cancers with long term follow up data, to analyze clinical impact of TIL expressing specific phenotypes and distribution of TILs within different tumor compartments and in different histological subtypes. A tissue microarray (TMA) including 894 ductal and 164 lobular breast cancers was stained with antibodies recognizing CD4, FOXP3, and IL-17 by standard immunohistochemical techniques. Lymphocyte counts were correlated with clinico-pathological parameters and survival. CD4+ lymphocytes were more prevalent than FOXP3+ TILs whereas IL-17+ TILs were rare. Increased numbers of total CD4+ and FOXP3+ TIL were observed in ductal, as compared with lobular carcinomas. High grade (G3) and estrogen receptor (ER) negative ductal carcinomas displayed significantly (p &lt; 0.001) higher CD4+ and FOXP3+ lymphocyte infiltration while her2/neu over-expression in ductal carcinomas was significantly (p &lt; 0.001) associated with higher FOXP3+ TIL counts. In contrast, lymphocyte infiltration was not linked to any clinico-pathological parameters in lobular cancers. In univariate but not in multivariate analysis CD4+ infiltration was associated with significantly shorter survival in patients bearing ductal, but not lobular cancers. However, a FOXP3+/CD4+ ratio &gt; 1 was associated with improved overall survival even in multivariate analysis (p = 0.033). Ductal and lobular breast cancers appear to be infiltrated by different lymphocyte subpopulations. In ductal cancers increased CD4+ and FOXP3+ TIL numbers are associated with more aggressive tumor features. In survival analysis, absolute numbers of TILs do not represent major prognostic indicators in ductal and lobular breast cancer. Remarkably however, a ratio &gt; 1 of total FOXP3+/CD4+ TILs in ductal carcinoma appears to represent an independent favorable prognostic factor.
      datePublished:2012-04-03T00:00:00Z
      dateModified:2012-04-03T00:00:00Z
      pageStart:1
      pageEnd:10
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2407-12-134
      keywords:
         Breast Cancer
         Ductal Carcinoma
         Lobular Carcinoma
         Tumor Infiltrate Lymphocyte
         Ductal Cancer
         Cancer Research
         Oncology
         Surgical Oncology
         Health Promotion and Disease Prevention
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-12-134/MediaObjects/12885_2011_Article_3146_Fig4_HTML.jpg
      isPartOf:
         name:BMC Cancer
         issn:
            1471-2407
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Raoul Droeser
            affiliation:
                  name:University Hospital Basel
                  address:
                     name:Department of Surgery, University Hospital Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
                  name:University of Basel
                  address:
                     name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Inti Zlobec
            affiliation:
                  name:University Hospital Bern
                  address:
                     name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
                     type:PostalAddress
                  type:Organization
                  name:University Hospital Basel
                  address:
                     name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ergin Kilic
            affiliation:
                  name:Charité University Hospital
                  address:
                     name:Institute for Pathology, Charité University Hospital, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Uwe Güth
            affiliation:
                  name:University Hospital Basel
                  address:
                     name:Department of Gynecology and Obstetrics, University Hospital Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael Heberer
            affiliation:
                  name:University of Basel
                  address:
                     name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giulio Spagnoli
            affiliation:
                  name:University of Basel
                  address:
                     name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daniel Oertli
            affiliation:
                  name:University Hospital Basel
                  address:
                     name:Department of Surgery, University Hospital Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Coya Tapia
            affiliation:
                  name:University Hospital Bern
                  address:
                     name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
                     type:PostalAddress
                  type:Organization
                  name:University Hospital Basel
                  address:
                     name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Cancer
      issn:
         1471-2407
      volumeNumber:12
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University Hospital Basel
      address:
         name:Department of Surgery, University Hospital Basel, Basel, Switzerland
         type:PostalAddress
      name:University of Basel
      address:
         name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
         type:PostalAddress
      name:University Hospital Bern
      address:
         name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
         type:PostalAddress
      name:University Hospital Basel
      address:
         name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
         type:PostalAddress
      name:Charité University Hospital
      address:
         name:Institute for Pathology, Charité University Hospital, Berlin, Germany
         type:PostalAddress
      name:University Hospital Basel
      address:
         name:Department of Gynecology and Obstetrics, University Hospital Basel, Basel, Switzerland
         type:PostalAddress
      name:University of Basel
      address:
         name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
         type:PostalAddress
      name:University of Basel
      address:
         name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
         type:PostalAddress
      name:University Hospital Basel
      address:
         name:Department of Surgery, University Hospital Basel, Basel, Switzerland
         type:PostalAddress
      name:University Hospital Bern
      address:
         name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
         type:PostalAddress
      name:University Hospital Basel
      address:
         name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Raoul Droeser
      affiliation:
            name:University Hospital Basel
            address:
               name:Department of Surgery, University Hospital Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
            name:University of Basel
            address:
               name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Inti Zlobec
      affiliation:
            name:University Hospital Bern
            address:
               name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
               type:PostalAddress
            type:Organization
            name:University Hospital Basel
            address:
               name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Ergin Kilic
      affiliation:
            name:Charité University Hospital
            address:
               name:Institute for Pathology, Charité University Hospital, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Uwe Güth
      affiliation:
            name:University Hospital Basel
            address:
               name:Department of Gynecology and Obstetrics, University Hospital Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Michael Heberer
      affiliation:
            name:University of Basel
            address:
               name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Giulio Spagnoli
      affiliation:
            name:University of Basel
            address:
               name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Daniel Oertli
      affiliation:
            name:University Hospital Basel
            address:
               name:Department of Surgery, University Hospital Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Coya Tapia
      affiliation:
            name:University Hospital Bern
            address:
               name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
               type:PostalAddress
            type:Organization
            name:University Hospital Basel
            address:
               name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Surgery, University Hospital Basel, Basel, Switzerland
      name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
      name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
      name:Institute for Pathology, University Hospital Basel, Basel, Switzerland
      name:Institute for Pathology, Charité University Hospital, Berlin, Germany
      name:Department of Gynecology and Obstetrics, University Hospital Basel, Basel, Switzerland
      name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
      name:Institute for Surgical Research and Hospital Management ICFS and Department of Biomedicine, University of Basel, Basel, Switzerland
      name:Department of Surgery, University Hospital Basel, Basel, Switzerland
      name:Institute for Pathology, University Hospital Bern, Bern, Switzerland
      name:Institute for Pathology, University Hospital Basel, Basel, Switzerland

External Links {🔗}(200)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.1s.